scispace - formally typeset
Open AccessJournal ArticleDOI

Nuclear Envelope Dispersion Triggered by Deregulated Cdk5 Precedes Neuronal Death

Reads0
Chats0
TLDR
It is shown that nuclear fragmentation in neurodegeneration is an early trigger for cell death initiated by deregulated Cdk5 and inhibition of nuclear fragmentation rescues neurons from cell death, underscoring the significance of this event in AD.
Abstract
Nuclear fragmentation is a common feature in many neurodegenerative diseases, including Alzheimer’s disease (AD). In this study, we show that nuclear lamina dispersion is an early and irreversible trigger for cell death initiated by deregulated Cdk5, rather than a consequence of apoptosis. Cyclin-dependent kinase 5 (Cdk5) activity is significantly increased in AD and contributes to all three hallmarks: neurotoxic amyloid-β (Aβ), neurofibrillary tangles (NFT), and extensive cell death. Using Aβ and glutamate as the neurotoxic stimuli, we show that deregulated Cdk5 induces nuclear lamina dispersion by direct phosphorylation of lamin A and lamin B1 in neuronal cells and primary cortical neurons. Phosphorylation-resistant mutants of lamins confer resistance to nuclear dispersion and cell death on neurotoxic stimulation, highlighting this as a major mechanism for neuronal death. Rapid alteration of lamin localization pattern and nuclear membrane change are further supported by in vivo data using an AD mouse model. After p25 induction, the pattern of lamin localization was significantly altered, preceding neuronal death, suggesting that it is an early pathological event in p25-inducible transgenic mice. Importantly, lamin dispersion is coupled with Cdk5 nuclear localization, which is highly neurotoxic. Inhibition of nuclear dispersion rescues neuronal cells from cell death, underscoring the significance of this event to Cdk5-mediated neurotoxicity.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Cdk5: a multifaceted kinase in neurodegenerative diseases

TL;DR: Recent findings on the involvement of Cdk5 in the pathophysiological mechanisms underlying various neurodegenerative diseases are summarized.
Journal ArticleDOI

The Role of Cdk5 in Alzheimer’s Disease

TL;DR: An inhibition of Cdk5 activity with inhibitors such as RNA inference (RNAi) could protect from memory decline and neuronal cell loss through suppressing β-amyloid (Aβ)-induced neurotoxicity and tauopathies.
Journal ArticleDOI

Cdk5 activity in the brain - multiple paths of regulation.

TL;DR: In this article, various mechanisms of cyclin dependent kinase-5 regulation, including several recently identified protein activators and inhibitors of Cdk5 that control its activity in normal and diseased brains, are discussed.
References
More filters
Journal ArticleDOI

Apoptosis and caspases in neurodegenerative diseases.

TL;DR: Pharmacologic interference with the induction or completion of apoptosis holds promise for the treatment of neurodegenerative diseases, and clinical trials with one such agent are already under way.
Journal ArticleDOI

Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity

TL;DR: The primary and secondary structures of β‐amyloid that are involved in its in vitro assembly into neurotoxic peptide aggregates are defined and may underlie both its pathological deposition and subsequent degenerative effects in Alzheimer's disease.
Journal ArticleDOI

Mutations of phosphorylation sites in lamin A that prevent nuclear lamina disassembly in mitosis

TL;DR: A model for the regulation of lamin assembly is proposed in which phosphorylation just outside the ends of the alpha-helical domain controls the assembly dynamics of the lamin coiled-coil dimers.
Journal ArticleDOI

Immunohistochemical evidence for apoptosis in Alzheimer's disease.

TL;DR: In vivo results support the hypothesis that apoptosis may be one mechanism leading neuronal cell death in AD.
Related Papers (5)